Back to Search Start Over

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.

Authors :
Davis, R. Eric
Ngo, Vu N.
Lenz, Georg
Tolar, Pavel
Young, Ryan M.
Romesser, Paul B.
Kohlhammer, Holger
Lamy, Laurence
Hong Zhao
Yandan Yang
Weihong Xu
Shaffer, Arthur L.
Wright, George
Wenming Xiao
Powell, John
Jian-kang Jiang
Thomas, Craig J.
Rosenwald, Andreas
Ott, German
Muller-Hermelink, Hans Konrad
Source :
Nature; 1/7/2010, Vol. 463 Issue 7277, p88-92, 5p, 4 Graphs
Publication Year :
2010

Abstract

A role for B-cell-receptor (BCR) signalling in lymphomagenesis has been inferred by studying immunoglobulin genes in human lymphomas and by engineering mouse models, but genetic and functional evidence for its oncogenic role in human lymphomas is needed. Here we describe a form of ‘chronic active’ BCR signalling that is required for cell survival in the activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL). The signalling adaptor CARD11 is required for constitutive NF-κB pathway activity and survival in ABC DLBCL. Roughly 10% of ABC DLBCLs have mutant CARD11 isoforms that activate NF-κB, but the mechanism that engages wild-type CARD11 in other ABC DLBCLs was unknown. An RNA interference genetic screen revealed that a BCR signalling component, Bruton’s tyrosine kinase, is essential for the survival of ABC DLBCLs with wild-type CARD11. In addition, knockdown of proximal BCR subunits (IgM, Ig-κ, CD79A and CD79B) killed ABC DLBCLs with wild-type CARD11 but not other lymphomas. The BCRs in these ABC DLBCLs formed prominent clusters in the plasma membrane with low diffusion, similarly to BCRs in antigen-stimulated normal B cells. Somatic mutations affecting the immunoreceptor tyrosine-based activation motif (ITAM) signalling modules of CD79B and CD79A were detected frequently in ABC DLBCL biopsy samples but rarely in other DLBCLs and never in Burkitt’s lymphoma or mucosa-associated lymphoid tissue lymphoma. In 18% of ABC DLBCLs, one functionally critical residue of CD79B, the first ITAM tyrosine, was mutated. These mutations increased surface BCR expression and attenuated Lyn kinase, a feedback inhibitor of BCR signalling. These findings establish chronic active BCR signalling as a new pathogenetic mechanism in ABC DLBCL, suggesting several therapeutic strategies. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00280836
Volume :
463
Issue :
7277
Database :
Complementary Index
Journal :
Nature
Publication Type :
Academic Journal
Accession number :
47343029
Full Text :
https://doi.org/10.1038/nature08638